Canada’s Drug Agency Unveils New Mandate and Future of Pharmaceutical Reviews | MARKET ACCESS 2024
In this comprehensive presentation, Dr. Farah Hussain provides an in-depth look at Canada’s Drug Agency’s expanded role and innovative initiatives. Canada’s Drug Agency is transforming pharmaceutical reviews through innovative initiatives like the Target Zero Initiative, rolling reviews, and real-world evidence …...
4 Game-Changing Healthcare Technology Trends Transforming Canadian Access | MARKET ACCESS 2024
During the eye-opening 2024 Market Access Summit, a panel featuring Ali Tarana, Angelique Berg, Dr Anne Snowden, and Toby Mitchell showcased the latest innovations that have the potential to transform healthcare equity across Canada. Key highlights of the discussion included …...
Rare Diseases Unveiled: The Critical Path to Patient Care | MARKET ACCESS 2024
In her presentation, Karen Heim, VP of Alexion Canada, highlights the hidden challenges faced by rare disease patients in Canada, including diagnostic delays and treatment barriers. Key points include the five-year diagnostic journey, the role of technology in early detection, …...
Outcome-Based Agreements: Transforming Healthcare Access in Canada | MARKET ACCESS 2024
Join Ina Hassani from LiveGen as she reveals groundbreaking insights into how Outcome-Based Agreements (OBAs) are revolutionizing pharmaceutical access and innovation. Key highlights include: 535+ global outcome-based agreements analyzed, challenges in the Canadian healthcare market access, and strategies for accelerating …...
